Kolexia
Galinat Hubert
Pharmacien
Hôpital Cavale Blanche
Brest, France
67 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thrombose Hémophilie A Hémorragie Syndromes myéloprolifératifs Mal de décompression Inflammation Thrombophilie Déficit en facteur XIII Tumeurs hématologiques

Industries

Bayer
2 collaboration(s)
Dernière en 2023
Inter-View Partners France
2 collaboration(s)
Dernière en 2021
LFB
2 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
1 collaboration(s)
Dernière en 2020

Dernières activités

Point-of-care testing for D-dimer in the exclusion of venous thromboembolism: a critical analysis.
Annales de biologie clinique   29 novembre 2023
Does Decreased Diffusing Capacity of the Lungs for Carbon Monoxide Constitute a Risk of Decompression Sickness in Occupational Divers?
International journal of environmental research and public health   03 août 2023
Microrheology and structural quantification of hypercoagulable clots.
Biomedical optics express   19 juillet 2023
Using an age and fibrinogen levels adjusted D-dimer cutoff significantly improves the specificity of two equivalent D-dimer assays for excluding pulmonary embolism.
Thrombosis research   14 juin 2023
Contribution of biology to the diagnosis and follow-up of VITT: A French multicentre experience
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Apport du dosage des monomères de fibrine en situations obstétricales aiguës.
Annales de biologie clinique   30 juin 2022
Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.
Thrombosis research   15 octobre 2021
Population Pharmacokinetics Modelling of prescribed factors VIII in patients with severe haemophilia A: Toward a global model explaining the main variability of pharmacokinetic parameters
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 15–16 June 2021, E‐meeting, France   02 juin 2021
PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia.
The New England journal of medicine   19 mai 2021
Use of Recombinant von Willebrand Factor Alone during Surgeries in Type 2 von Willebrand Patients: Case Reports
Abstracts of the ISTH 2020 Virtual Congress of the International Society on Thrombosis and Haemostasis, July 12–14, 2020   11 août 2020